Skip to content Skip to navigation

Senators Request Clarity on mHealth App Regulation from FDA

March 19, 2014
by Gabriel Perna
| Reprints

A group of U.S. Senators have sent a letter to Food and Drug Administration (FDA) Commissioner, Margaret A. Hamburg, M.D. seeking further clarity and transparency on how the agency plans on regulating medical mobile health (mHealth) apps.

Senators Michael Bennet (D-Colo.), Orrin Hatch (R-Utah), Tom Harkin (D-Iowa), Lamar Alexander (R-Tenn), Mark Warner (D-Va), and Richard Burr (R-NC) sent the letter to Dr. Hamburg, asking for further clarification  for medical software application developers. Referring to the FDA's final guidance over mHealth apps, the Senators note that the agency used a risk-based approach in defining what it considers to be a mobile medical application, focused on high-risk medical software in particular. The Senators say a large number of apps could be actively regulated under this definition and more transparency is required for developers.

"While the FDA’s final guidance has provided clarity on the agency’s approach to regulation of mobile medical applications, we believe more transparency is needed to avoid stakeholder confusion over how a wider range of medical software might be appropriately regulated," the Senators wrote in the letter.

The Senators include a series of questions within the letter that it requests the FDA answer within three weeks of its receipt. Some of those questions include:

  • Compared to current FDA guidance, what impact would Congress establishing categories of medical software in legislation have on the FDA’s oversight of medical mobile applications?
  • What role, if any, can statutory definitions play to clarify any uncertainty with respect to assigning risk level to medical software?

  • How is the FDA determining what types of medical software updates, even minor updates, change the function of or add a function to the medical software and would require FDA review?

  • How has the FDA been coordinating with the Office of the National Coordinator and Federal Communications Commission to address the recent FDA Safety and Innovation Act working group’s concerns over interoperability?

The letter, in its entirety, can be read by clicking the link below.


Read the source article at Michael Bennet



CMS Hospital Compare Website Updated with VA Data

The Centers for Medicare & Medicaid Services (CMS) has announced the inclusion of Veterans Administration (VA) hospital performance data as part of the federal agency’s Hospital Compare website.

CMS Awards Funding to Special Innovation Projects

The Centers for Medicare & Medicaid Services (CMS) has awarded 20, two-year Special Innovation Projects (SIPs) aimed at local efforts to deliver better care at lower cost.

Center of Excellence in Genomic Science to be Established in Chicago

The National Human Genome Research Institute has awarded $10.6 million over five years for the establishment of a new research center in Chicago to advance genomic science.

EHNAC and HITRUST Combine HIPAA Security Criteria, CSF Framework

The Electronic Healthcare Network Accreditation Commission (EHNAC) and the Health Information Trust Alliance (HITRUST) announced plans to streamline their accreditation and certification programs.

Halamka on MACRA Final Rule: “CMS is Listening and I Thank Them”

Health IT notable expert John Halamka, M.D., CIO of Beth Israel Deaconess Medical Center in Boston, recently weighed in on the Medicare Access and CHIP Reauthorization Act (MACRA) final rule.

Texas Patient Care Clinic Hit with Ransomware Attack

Grand Prairie, Texas-based Rainbow Children's Clinic was the victim of a ransomware attack on its IT systems in August, affecting more than 33,000 patients, according to multiple news media reports this week.